CCCC vs REGN: Which Stock is Better?
Side-by-side comparison of C4 Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026
CCCC
C4 Therapeutics Inc
$2.97
REGN
Regeneron Pharmaceuticals Inc
$751.57
Key Metrics Comparison
| Metric | CCCC | REGN | Winner |
|---|---|---|---|
| Market Cap | $299.56M | $79.46B | REGN |
| P/E Ratio | N/A | 18.11 | REGN |
| EPS (TTM) | $N/A | $41.49 | REGN |
| Revenue Growth | 1.1% | 0.0% | CCCC |
| Gross Margin | 75.0% | 44.6% | CCCC |
Analyze CCCC
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CCCC or REGN a better investment?
Comparing CCCC and REGN: C4 Therapeutics Inc has a market cap of $299.56M while Regeneron Pharmaceuticals Inc has $79.46B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CCCC and REGN?
CCCC (C4 Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CCCC or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CCCC or REGN?
CCCC has higher revenue growth at 1.1% vs 0.0% for REGN.
Which company is more profitable: CCCC or REGN?
C4 Therapeutics Inc (CCCC) has higher gross margins at 75.0% compared to 44.6% for REGN.
Which is the larger company: CCCC or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.46B compared to $299.56M for CCCC.
Should I buy CCCC or REGN in 2026?
Both CCCC and REGN have investment merit. CCCC trades at $2.97 while REGN trades at $751.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CCCC and REGN stock?
Key differences: Market Cap ($299.56M vs $79.46B), P/E Ratio (N/A vs 18.1x), Revenue Growth (1.1% vs 0.0%), Gross Margin (75.0% vs 44.6%).